Alphabet Inc.’s Isomorphic Labs, which is working to design latest drugs with artificial intelligence, has raised $5 billion in a funding round helmed by Silicon Valley titans just six months after announcing its last fundraising effort.
Alphabet Inc.’s Isomorphic Labs, which is working to design latest drugs with artificial intelligence, has raised $5 billion in a funding round helmed by Silicon Valley titans just six months after announcing its last fundraising effort.